{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:02Z","timestamp":1791348602262,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104492","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:34:03Z","timestamp":1788478443000},"page":"104492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced transungual delivery from a film-forming nail platform under wash conditions: Evidence from bovine hoof and human nail models"],"prefix":"10.1016","volume":"115","author":[{"given":"Jing","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8005-381X","authenticated-orcid":false,"given":"Zeren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xphs.2026.104492_bib0001","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jdv.12323","article-title":"The prevalence of onychomycosis in the global population: a literature study","volume":"28","author":"Sigurgeirsson","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104492_bib0002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1203475417716362","article-title":"Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment","volume":"21","author":"Gupta","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.xphs.2026.104492_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jof1010030","article-title":"Onychomycosis: a review","volume":"1","author":"Piraccini","year":"2015","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.xphs.2026.104492_bib0004","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.12178","article-title":"Risk of oral antifungal agent-induced liver injury in Taiwanese","volume":"77","author":"Kao","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104492_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0733-8635(03)00037-8","article-title":"Oral antifungal drug interactions: a mechanistic approach to understanding their cause","volume":"21","author":"Katz","year":"2003","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.xphs.2026.104492_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","article-title":"In-vitro permeability of the Human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104492_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2310\/7750.2014.14090","article-title":"Management of onychomycosis in Canada in 2014","volume":"19","author":"Gupta","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.xphs.2026.104492_bib0008","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jps.2600501018","article-title":"Rate of release of medicaments from ointment bases containing drugs in suspension","volume":"50","author":"Higuchi","year":"1961","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104492_bib0009","first-page":"487","article-title":"Film forming systems for topical and transdermal drug delivery","volume":"12","author":"Kathe","year":"2017","journal-title":"Asian J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104492_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/jof8101079","article-title":"Novel and investigational treatments for onychomycosis","volume":"8","author":"Gregoriou","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.xphs.2026.104492_bib0011","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12249-023-02603-x","article-title":"Contemporary techniques and potential transungual drug delivery nanosystems for the treatment of onychomycosis","volume":"24","author":"Abd-Elsalam","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2026.104492_bib0012","article-title":"Novel discoveries and clinical advancements for treating onychomycosis: a mechanistic insight","volume":"205","author":"Behera","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104492_bib0013","article-title":"Transungual drug delivery: a holistic review of nail anatomy, penetration enhancement techniques, formulation strategies, and experimental models","volume":"114","author":"Kandav","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104492_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104492_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229414","article-title":"Assessment of the nail penetration of antifungal agents, with different physico-chemical properties","volume":"15","author":"Davies-Strickleton","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.xphs.2026.104492_bib0016","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2016.03.008","article-title":"An investigation of how fungal infection influences drug penetration through onychomycosis patient\u2019s nail plates","volume":"102","author":"McAuley","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104492_bib0017","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2026.104492_bib0018","series-title":"Clenafin (Efinaconazole Topical Solution) Interview Form","year":"2025"},{"issue":"7","key":"10.1016\/j.xphs.2026.104492_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159661","article-title":"Efficacy coefficients determined using nail permeability and antifungal activity in keratin-containing Media are useful for predicting clinical efficacies of topical drugs for onychomycosis","volume":"11","author":"Matsuda","year":"2016","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.xphs.2026.104492_bib0020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.02056-12","article-title":"Comparison of In vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis","volume":"57","author":"Jo Siu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.xphs.2026.104492_bib0021","first-page":"58","article-title":"Fungicidal activity in the presence of Keratin as an important factor contributing to In vivo efficacy: a comparison of Efinaconazole, Tavaborole, and Ciclopirox","volume":"3","author":"Tachibana","year":"2017","journal-title":"J Fungi(Basel)"},{"issue":"1","key":"10.1016\/j.xphs.2026.104492_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaad.2020.06.055","article-title":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: a randomized, multicenter, double-blind, vehicle-controlled phase 3 study","volume":"85","author":"Gupta","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2026.104492_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2230.1992.tb00278.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly","volume":"17","author":"Reinel","year":"1992","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104492_bib0024","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2026.104492_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2230.1992.tb00273.x","article-title":"Loceryl\u00ae Nail Lacquer - realization of a new galenical approach to onychomycosis therapy","volume":"17","author":"Pittrof","year":"1992","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104492_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/17425247.2016.1124412","article-title":"The potential of polymeric film-forming systems as sustained delivery platforms for topical drugs","volume":"13","author":"Frederiksen","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.xphs.2026.104492_bib0027","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/pharmaceutics11060290","article-title":"Controlled release film forming systems in drug delivery: the potential for efficient drug delivery","volume":"11","author":"Tran","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104492_bib0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.2011.10303.x","article-title":"Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation","volume":"165","author":"Monti","year":"2011","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.xphs.2026.104492_bib0029","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/pharmaceutics13122098","article-title":"Improving transungual permeation study design by increased bovine hoof membrane thickness and subsequent infection","volume":"13","author":"Kappes","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.xphs.2026.104492_bib0030","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11095-007-9368-3","article-title":"Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers","volume":"24","author":"Khengar","year":"2007","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104492_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.002","article-title":"Transungual drug delivery: current status","volume":"384","author":"Elkeeb","year":"2010","journal-title":"Int J Pharm"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2026.104492_bib0032","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2007.07.009","article-title":"Effect of hydration on the permeation of ketoconazole through human nail plate in vitro","volume":"32","author":"Gunt","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104492_bib0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","article-title":"Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum","volume":"35","author":"Walters","year":"1983","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104492_bib0034","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/03639045.2011.637931","article-title":"Ungual and transungual drug delivery","volume":"38","author":"Shivakumar","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104492_bib0035","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00111-14","article-title":"The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment","volume":"58","author":"Sugiura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.xphs.2026.104492_bib0036","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/jof10090620","article-title":"Extended use of topical efinaconazole remains safe and can provide continuing benefits for dermatophyte toenail onychomycosis","volume":"10","author":"Gupta","year":"2024","journal-title":"J Fungi"},{"issue":"5","key":"10.1016\/j.xphs.2026.104492_bib0037","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/myc.12592","article-title":"Understanding the formidable nail barrier: a review of the nail microstructure, composition and diseases","volume":"60","author":"Baswan","year":"2017","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.xphs.2026.104492_bib0038","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","article-title":"Drug permeation through the three layers of the human nail plate","volume":"51","author":"Kobayashi","year":"1999","journal-title":"J Pharm Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:02Z","timestamp":1791345242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003424"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104492","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced transungual delivery from a film-forming nail platform under wash conditions: Evidence from bovine hoof and human nail models","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104492"}}